Drug Profile
PEP 010 companion biomarker diagnostics - PEP-Therapy
Alternative Names: DPT-C9h companion biomarkersLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator PEP-Therapy
- Class Diagnostic agents
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Cancer(Diagnosis) in France
- 25 Jul 2016 Early research in Cancer (Diagnosis) in France (unspecified route)